Digital Collections - National Library of Medicine

« Previous Next »

A-Z Sort Numerical Sort

Buprenorphine: an overview for clinicians1
Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS Buprenorphine Practice Guidelines1
Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report1
Increasing access to medications for opioid use disorder: policy strategies during and after COVID-19 pandemic1
MAT for hospitalized patients1
MAT for opioid use disorder: overcoming objections1
MAT in community health centers1
MAT in the emergency department: FAQ1
Management of patients with opioid dependence: a review of clinical, delivery system, and policy options1
Opioid use disorder: developing depot buprenorphine products for treatment1
Opioid use disorder: treatment with injectable and implantable buprenorphine : report to Congressional committees1
Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate1
Primary care: on the front lines of the opioid epidemic1
Show me the money: economic evaluations of opioid use disorder interventions1
Substance use disorder in America: research to practice, and back again addressing the gaps in evidence-based policy and practice1
Substance use in California: a look at addiction and treatment1
The role of community health centers in addressing the opioid epidemic1
Why health plans should go to the "MAT" in the fight against opioid addiction1

Titles